SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Insmed Incorporated of Commencement of a Class Action Lawsu...
19 Juillet 2016 - 6:14PM
The following statement is being issued by Levi & Korsinsky,
LLP:
To: All persons or entities who
purchased or otherwise acquired securities of
Insmed Incorporated (“Insmed” or the “Company”)
(NASDAQ:INSM) between March 18, 2013 and June 8,
2016.
You are hereby notified that a
securities class action has commenced in the USDC for the District
of New Jersey. If you purchased or otherwise acquired Insmed
securities between March 18, 2013 and June 8, 2016, your rights may
be affected by this action. To get more information go
to:
http://www.zlk.com/pslra/insmed-incorporated.
The complaint alleges that, throughout the Class
Period, defendants issued false and misleading statements to
investors and/or failed to disclose that: (1) the data supporting
Insmed’s European marketing authorization application (“MAA”) for
lead product candidate ARIKAYCE was not likely to be approved by
the European Medicines Agency (“EMA”) for the treatment of NTM lung
disease, and (2) therefore ARIKAYCE’S approval by the EMA and
subsequent commercialization in Europe were less likely and/or
imminent than Insmed led investors to believe.
On June 8, 2016, Insmed announced it had
withdrawn its MAA for ARIKAYCE from the EMA, revealing that the
Committee for Medicinal Products for Human Use indicated that the
phase 2 study did not provide a sufficient amount of evidence to
support an approval.
If you suffered a loss in Insmed you
have until September 13, 2016 to request that the Court
appoint you as lead plaintiff. Your ability to share in any
recovery doesn’t require that you serve as a lead plaintiff. To
obtain additional information, contact Joseph E. Levi, Esq. either
via email at jlevi@zlk.com or by telephone at (212) 363-7500,
toll-free: (877) 363-5972, or visit
http://www.zlk.com/pslra/insmed-incorporated.
Levi & Korsinsky is a national firm with
offices in New York, New Jersey, California, Connecticut, and
Washington D.C. The firm’s attorneys have extensive experience
representing investors in securities litigation involving financial
fraud, and have recovered hundreds of millions of dollars for
aggrieved shareholders. Attorney advertising. Prior results do not
guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com
Insmed (NASDAQ:INSM)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024
Insmed (NASDAQ:INSM)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024